Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Int J Behav Med. 2020 Oct;27(5):490–505. doi: 10.1007/s12529-019-09839-7

Table 2.

Sample Characteristics

Full sample (N = 192) CBSM (n = 95) HP (n = 97)
Age; mean (SD) 68.84 (8.87) 68.81 (8.54) 68.87 (9.23)
Years since diagnosis; mean (SD) 4.70 (5.28) 4.36 (5.16) 5.05 (5.41)
# sessions completed; mean (SD) 7.69 (2.97) 7.47 (3.09) 7.90 (2.86)
Days between session 10 and T2; mean (SD) 76.43 (38.51) 76.77 (38.81) 76.10 (38.44)
Months since most recent ADT tx; mean (SD)
T1 1.52 (1.53) 1.61 (1.61) 1.43 (1.44)
T2 2.33 (2.46) 2.58 (2.58) 2.10 (2.32)
T3 3.20 (3.86) 3.60 (4.51) 2.81 (3.09)
Race; n (%)
White 113 (58.9) 56 (58.9) 57 (58.8)
Black 69 (35.9) 35 (36.8) 34 (35.1)
Other 10 (5.2) 4 (4.3) 6 (6.2)
Married or equivalent; n (%) 128 (66.7) 67 (70.5) 61 (62.9)
Family annual income ≥ $35,000; n (%) 125 (65.1) 66 (69.5) 59 (60.8)
Working full- or part-time; n (%) 74 (38.5) 31 (32.6) 43 (44.3)
Metastatic group; n (%) 81 (42.2) 37 (38.9) 44 (45.4)
Prostate cancer treatment history; n (%)
Received tx within 6-months prior to T1 156 (81.3) 80 (84.2) 76 (78.4)
and/or has a history of RRP Received tx between T1 and T2 47 (24.5) 22 (23.2) 25 (25.8)
Received tx within T2 and T3 22 (11.5) 10 (10.5) 12 (12.4)
Recruitment site; n (%)
Northwestern Memorial Hospital 111 (57.8) 58 (61.1) 53 (54.6)
Jesse Brown VA 42 (21.9) 18 (18.9) 24 (24.7)
Rush University Medical Center 34 (17.7) 19 (20.0) 15 (15.5)
Other 5 (2.6) 0 (0.0) 5 (5.1)

CBSM, cognitive-behavioral stress management group; HP, health promotion group; SD, standard deviation; ADT, androgen deprivation therapy; tx, treatment